2023
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
Song T, Shin J, Yon D, Lee S, Hwang S, Hwang J, Park S, Lee S, Lee M, Kim M, Koyanagi A, Tizaoui K, Kim J, Smith L. Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review. European Review For Medical And Pharmacological Sciences 2023, 27: 404-410. PMID: 36647889, DOI: 10.26355/eurrev_202301_30894.Peer-Reviewed Original ResearchConceptsCerebral venous thrombosisChAdOx1 nCoV-19 vaccineIntracerebral hemorrhageThrombocytopenia syndromeCase seriesVenous thrombosisCase reportPresence of cerebral venous thrombosisSystematic review of case reportsDose of ChAdOx1 nCoV-19 vaccineHistory of intracerebral hemorrhageReview of case reportsSystematic reviewHigher mortality rateYounger age groupsClinical featuresLaboratory findingsTreatment modalitiesFrequent historyMultivariate analysisWeb of Science databasesThrombosisPatientsMortality rateAge groups
2022
Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series
Park D, An S, Kaur A, Malhotra S, Vij A. Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series. Clinical Cardiology 2022, 45: 691-700. PMID: 35652390, PMCID: PMC9286338, DOI: 10.1002/clc.23828.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccine-associated myocarditisVaccine-associated myocarditisCOVID-19 mRNA vaccinesMRNA vaccinesSystematic review of case reportsCOVID-19 vaccineReview of case reportsAverage time to onsetElevation of troponinNonsteroidal anti-inflammatory drugsCases of myocarditisDisease severity of COVID-19Time to onsetLength of hospitalizationOccurrence of myocarditisDose of COVID vaccineAnti-inflammatory drugsPain 3Severity of COVID-19Anti-COVID-19 vaccineSystematic literature searchChest painFavorable prognosisCase seriesClinical characteristics
2013
The National Cancer Institute Best Case Series Program
Olaku O, Zia F, Santana J, White J. The National Cancer Institute Best Case Series Program. Integrative Cancer Therapies 2013, 12: 385-392. PMID: 23355475, DOI: 10.1177/1534735412473641.Peer-Reviewed Original ResearchConceptsNational Cancer InstituteAlternative medicine modalitiesCase reportRetrospective review of case reportsEvidence of tumor regressionReview of case reportsTreat cancerHomeopathic therapyReview of medical recordsReviewed case reportsMedicine modalitiesUnconventional therapiesTumor regressionRetrospective reviewMedical recordsCancer InstitutePreclinical evaluationConventional treatmentProspective researchTherapyForty-onePreliminary evidenceCancerProgramPractitioners
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply